{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:04:30Z","timestamp":1791345870520,"version":"4.3.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum des Saarlandes und Medizinische Fakult\u00e4t der Universit\u00e4t des Saarlandes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent studies have shown that a ketogenic diet containing medium-chain triglycerides (MCTs) has a synergistic effect with perampanel in modulating AMPA receptors. Both MCTs and perampanel have immunomodulatory properties. However, the use of the combination of MCTs and perampanel to treat status epilepticus caused by autoimmune encephalitis has never been investigated. After multiple antiseizure (benzodiazepines, levetiracetam, brivaracetam, lacosamide, ketamine, propofol, and isoflurane) and immunomodulatory treatments (glucocorticoid pulse (days 4\u20138), intravenous immunoglobulin (days 10\u201312), plasmapheresis (days 13\u201319), rituximab (days 22 and 34), cyclophosphamide (day 38)), failed to interrupt status epilepticus in a 33-year-old woman caused by paraneoplastic anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, we initiated perampanel treatment (12\u00a0mg\/day), which significantly reduced ictal activity in the EEG. Status epilepticus was finally terminated when MCTs were added to the perampanel treatment regimen. Our clinical data may support previous in vitro studies demonstrating that combining perampanel with MCTs improves the neuroimmunomodulatory effect on AMPA receptors. MCTs may have a synergistic effect when added to perampanel to treat autoimmune status epilepticus. The possible cumulative effects of combination with other immune therapies in our case cannot be completely excluded.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s11481-026-10295-w","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:40:30Z","timestamp":1779180030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroimmunomodulation of AMPA Receptors Through Combination of Medium-Chain Triglycerides and Perampanel to Treat Status Epilepticus in Anti-NMDA Receptor Encephalitis"],"prefix":"10.1007","volume":"21","author":[{"given":"Laura Marie","family":"Stadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurin","family":"Schappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Bonifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Fousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-4038","authenticated-orcid":false,"given":"Yaroslav","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"10295_CR1","doi-asserted-by":"publisher","first-page":"e14033","DOI":"10.1097\/MD.0000000000014033","volume":"98","author":"H Akiyama","year":"2019","unstructured":"Akiyama H, Sasaki R, Hasegawa Y (2019) Efficacy of perampanel for anti-N-methyl-D-aspartate receptor encephalitis: a case report. Medicine 98:e14033","journal-title":"Medicine"},{"key":"10295_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, Heales SJR, Walker MC, Williams RSB (2018) Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol 17:84\u201393","journal-title":"Lancet Neurol"},{"key":"10295_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","volume":"69","author":"P Chang","year":"2013","unstructured":"Chang P, Terbach N, Plant N, Chen PE, Walker MC, Williams RS (2013) Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology 69:105\u2013114","journal-title":"Neuropharmacology"},{"key":"10295_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5005\/jp-journals-10071-24073","volume":"26","author":"K Dutta","year":"2022","unstructured":"Dutta K, Satishchandra P, Borkotokey M (2022) Medium-chain triglyceride ketogenic diet as a treatment strategy for adult super-refractory status epilepticus. Indian J Crit care medicine: peer-reviewed official publication Indian Soc Crit Care Med 26:139\u2013140","journal-title":"Indian J Crit care medicine: peer-reviewed official publication Indian Soc Crit Care Med"},{"issue":"11","key":"10295_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/nu17111805","volume":"17","author":"R Falsaperla","year":"2025","unstructured":"Falsaperla R, Sortino V, Soler MA, Spatuzza M, Fortuna S, Salpietro V (2025) AMPA receptor modulation through medium-chain triglycerides and decanoic acid supports nutritional intervention in pediatric epilepsy. Nutrients 17(11):1805","journal-title":"Nutrients"},{"issue":"23","key":"10295_CR6","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/nu16233994","volume":"16","author":"D Guerreiro","year":"2024","unstructured":"Guerreiro D, Almeida A, Ramalho R (2024) Ketogenic diet and neuroinflammation: implications for neuroimmunometabolism and therapeutic approaches to refractory epilepsy. Nutrients 16(23):3994","journal-title":"Nutrients"},{"key":"10295_CR7","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1021\/jm301268u","volume":"55","author":"S Hibi","year":"2012","unstructured":"Hibi S, Ueno K, Nagato S, Kawano K, Ito K, Norimine Y, Takenaka O, Hanada T, Yonaga M (2012) Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem 55:10584\u201310600","journal-title":"J Med Chem"},{"key":"10295_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-5-31","volume":"5","author":"M Manto","year":"2010","unstructured":"Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J (2010) In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis 5:31","journal-title":"Orphanet J Rare Dis"},{"key":"10295_CR9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41430-019-0471-4","volume":"73","author":"T Prasoppokakorn","year":"2019","unstructured":"Prasoppokakorn T, Jirasakuldej S, Lakananurak N (2019) Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review. Eur J Clin Nutr 73:1594\u20131597","journal-title":"Eur J Clin Nutr"},{"key":"10295_CR10","doi-asserted-by":"publisher","first-page":"fcab160","DOI":"10.1093\/braincomms\/fcab160","volume":"3","author":"NE Schoeler","year":"2021","unstructured":"Schoeler NE, Orford M, Vivekananda U, Simpson Z, Van de Bor B, Smith H, Balestrini S, Rutherford T, Brennan E, McKenna J, Lambert B, Barker T, Jackson R, Williams RSB, Sisodiya SM, Eaton S, Heales SJR, Cross JH, Walker MC (2021) K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy. Brain Commun 3:fcab160","journal-title":"Brain Commun"},{"key":"10295_CR11","doi-asserted-by":"publisher","first-page":"1524799","DOI":"10.3389\/fneur.2025.1524799","volume":"16","author":"HJ Shin","year":"2025","unstructured":"Shin HJ, Ryu S, Lee N, Lee E, Ko A, Kang HC, Lee JS, Kim SH, Kim HD (2025) Decanoic acid-enriched ketogenic diet in refractory epilepsy. Front Neurol 16:1524799","journal-title":"Front Neurol"},{"key":"10295_CR12","doi-asserted-by":"publisher","first-page":"105633","DOI":"10.1016\/j.nbd.2022.105633","volume":"165","author":"T Singh","year":"2022","unstructured":"Singh T, Batabyal T, Kapur J (2022) Neuronal circuits sustaining neocortical-injury-induced status epilepticus. Neurobiol Dis 165:105633","journal-title":"Neurobiol Dis"},{"key":"10295_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","volume":"68","author":"A Vasquez","year":"2019","unstructured":"Vasquez A, Farias-Moeller R, Tatum W (2019) Pediatric refractory and super-refractory status epilepticus. Seizure 68:62\u201371","journal-title":"Seizure"},{"key":"10295_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3389\/fneur.2019.00684","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Ma C, Liu CY, Li GJ, Zhao D, Han DF (2019) Neuronal NMDAR currents of the hippocampus and learning performance in autoimmune Anti-NMDAR encephalitis and involvement of TNF-\u03b1 and IL-6. Front Neurol 10:684","journal-title":"Front Neurol"},{"key":"10295_CR15","doi-asserted-by":"publisher","first-page":"eads6434","DOI":"10.1126\/scitranslmed.ads6434","volume":"17","author":"B Wasser","year":"2025","unstructured":"Wasser B, Ecker M, Hanuscheck N, Ellwardt E, G\u00e4rtner Y, Engeroff K, Domingues M, Gr\u00fcnewald B, Oshaghi M, Wollnitzke P, Schroeter CB, Schmidt MHH, Muthuraman M, Levkau B, Winter Y, Meuth SG, Nitsch R, von Engelhardt J, Bittner S, Zipp F (2025) AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes. Sci Transl Med 17:eads6434","journal-title":"Sci Transl Med"},{"key":"10295_CR16","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1007\/s00415-023-11825-9","volume":"270","author":"Y Winter","year":"2023","unstructured":"Winter Y, Sandner K, Glaser M, Ciolac D, Sauer V, Ziebart A, Karakoyun A, Chiosa V, Saryyeva A, Krauss J, Ringel F, Groppa S (2023) Synergistic effects of vagus nerve stimulation and antiseizure medication. J Neurol 270:4978\u20134984","journal-title":"J Neurol"},{"key":"10295_CR18","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4014\/jmb.1703.03071","volume":"27","author":"S Yu","year":"2017","unstructured":"Yu S, Choi JH, Kim HJ, Park SH, Go GW, Kim W (2017) In vitro evidence of anti-inflammatory and anti-obesity effects of medium-chain fatty acid-diacylglycerols. J Microbiol Biotechnol 27:1617\u20131627","journal-title":"J Microbiol Biotechnol"},{"key":"10295_CR17","first-page":"8","volume-title":"Medium Chain Triglyceride (MCT) Oil Affects the Immunophenotype via Reprogramming of Mitochondrial Respiration in Murine Macrophages","author":"S Yu","year":"2019","unstructured":"Yu S, Go GW, Kim W (2019) Medium chain triglyceride (MCT) oil affects the immunophenotype via reprogramming of mitochondrial respiration in murine macrophages. Foods, Basel, Switzerland, p 8"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-026-10295-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:40:32Z","timestamp":1779180032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-026-10295-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10295"],"URL":"https:\/\/doi.org\/10.1007\/s11481-026-10295-w","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Was received from the local ethics committee (118\/25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The patient gave her written consent for publication of this case, including her identifiable data\/images. All authors agree to the submission, aligning with ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"26"}}